The new SCAI initiative brings optimism for a population that has seen little innovation or changes to treatment paradigms in ...

The trial’s findings will dampen enthusiasm for the drug in stroke recovery, though research questions remain, one expert ...

In 2023, there were 437 million disability-adjusted life-years lost from cardiovascular disease, up from 320 million in 1990.

Juan Granada and Sammy Elmariah discuss challenges that impact treatment plans for patients with severe aortic stenosis.

The drug met primary safety and efficacy outcomes, with full results to be presented at the AHA Scientific Sessions.

By beginning in hospital, researchers hope to kickstart LDL-lowering with a drug class that has been difficult to access.

EchoNet-Measurements shows promise against sonographers and in an external validation set but needs prospective study.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

The TCTMD team discusses their favorite stories from this past month, while special guest Robert Roswell breaks down the DAPT ...